← Every company
Alkermes Plc Lobbying
What Alkermes Plc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
ALKS on carbonthat →Disclosed spend
$3.1M
across every filing on file
Filings
23
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesMedicare/MedicaidPharmacyAlcohol and Drug AbuseTariff (miscellaneous tariff bills)
23 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | ALKERMES, INC.Medicare/MedicaidHealth Issues | $1M |
| 20262nd Quarter (Apr 1 - June 30) | ALKERMES, INC.Medicare/MedicaidHealth Issues | $930K |
| 20262nd Quarter (Apr 1 - June 30) | THORN RUN PARTNERSHealth IssuesMedicare/Medicaid | $90K |
| 20262nd Quarter (Apr 1 - June 30) | BALLARD PARTNERSMedicare/Medicaid | $90K |
| 20261st Quarter (Jan 1 - Mar 31) | S-3 GROUPAlcohol and Drug Abuse | $80K |
| 20262nd Quarter (Apr 1 - June 30) | S-3 GROUPAlcohol and Drug Abuse | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | PENN AVENUE PARTNERSPharmacy | $80K |
| 20262nd Quarter (Apr 1 - June 30) | PENN AVENUE PARTNERSPharmacy | $80K |
| 20262nd Quarter (Apr 1 - June 30) | CROSSROADS STRATEGIES, LLCPharmacy | $60K |
| 20262nd Quarter (Apr 1 - June 30) | LMH STRATEGIC SOLUTIONSMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | THORN RUN PARTNERSHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | LMH STRATEGIC SOLUTIONSMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPHealth Issues | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | SPLITOAK STRATEGIES LLCMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | SPLITOAK STRATEGIES LLCMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | TODD STRATEGY GROUPHealth Issues | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | CROSSROADS STRATEGIES, LLCPharmacy | $50K |
| 20262nd Quarter (Apr 1 - June 30) | BGR GOVERNMENT AFFAIRSHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | BGR GOVERNMENT AFFAIRSHealth Issues | $50K |
| 20262nd Quarter (Apr 1 - June 30) | MONUMENT ADVOCACY | — |
| 20262nd Quarter (Apr 1 - June 30) | MONUMENT ADVOCACYMedicare/Medicaid | — |
| 20261st Quarter (Jan 1 - Mar 31) | BALLARD PARTNERS | — |
| 20261st Quarter (Jan 1 - Mar 31) | CROSSROADS STRATEGIES, LLCPharmacy | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on ALKS
Company overviewEverything on ALKS in one place, with the price.SEC filingsWhat ALKS's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat ALKS's own officers and directors buy and sell.Executive payWhat ALKS awarded its chief executive, and what it became.Who lobbies for itThe lobbyists on ALKS's account, and who they worked for.PatentsWhat ALKS is filing at the patent office.